Edward Benz
Hematology · Boston, MANPI 1629069075
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $746,754 of the $746,999 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Deciphera Pharmaceuticals Inc.. Reporting peaked in 2023 at $396,155 and has fallen 92.3% since, to $30,620 in 2024. Among hematology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 20 payments — averaging $37,350 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Deciphera Pharmaceuticals Inc.$747K
What the payments were for
- Speaking & faculty fees$746,754100%
- Food & beverage$2450%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Deciphera Pharmaceuticals Inc. | 20 | $746,999 |
How this compares
$746,999 in reported general payments places this provider in the 95th percentile of 77 hematology providers in Massachusetts.
Other hematology in Boston
- David KuterBoston$543K
- Jacalyn RosenblattBoston$455K
- Lynn BryBoston$286K
- John SloanBoston$257K
- Andrew EvensBoston$217K
- Omar NadeemBoston$191K
- Nathan ConnellBoston$145K
- Jean ConnorsBoston$144K
- Heather BenjaminBoston$106K
- Martin SteinbergBoston$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.